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Abstract
Background The rehabilitation needs of patients with
metastatic breast cancer (MBC) are poorly studied. The
primary aim of the study was to evaluate the functional
capacity of women with MBC and quality of life (QoL).
Methods The present study is an open, non-randomized,
prospective cross-sectional observation study. The func-
tional capacity of 128 MBC patients with ongoing cancer
treatments, were studied in Helsinki University Hospital
(HUS): Peak expiratory flow (PEF), dynamic and static
balance, 6 minute walking distance (6MWD), 10 meter
walking, sit-to-stand test, repeated squat, grip strength,
shoulder movement, pain, and QoL by Beck’s depression
scale (BDI), health assessment questionnaire (HAQ),
RAND SF-36 and EORTC QLQ-30 items.
Results The walking capacity was compromised in half
and the strength of the lower extremities in one-third of the
patients. PEF was below the normal reference in 55 %,
static balance in 62 % and dynamic balance in 73 %
(B60 year olds) and 81 % (C61 year olds). The grip power
was lowered in 44/30 % of the patients (right/left) and the
shoulder movement was restricted in 30 %. Some disability
in physical functioning experienced 55 % (HAQ) and 37 %
felt depressive (BDI). The QoL (RAND SF-36) was poor
especially in the field of physical, role and social func-
tioning and bodily pain (\0.001). Pain, depression, and a
poor 6MWD results independently determined the physical
component of QoL (p\ 0.001).
Conclusions The functional capacity of patients with
MBC was significantly lowered. This, in association with
distressing symptoms like pain and depression causes a
vicious circle further leading to functional disabilities and
impaired QoL.
Keywords Breast cancer  Disability  Metastatic 
Quality of life  Rehabilitation
Introduction
In recent years, the survival of women with metastatic
breast cancer (MBC) has improved because of the advan-
ces in cancer-specific therapies. According to a Canadian
population based cohort study, a median survival of
patients with MBC has improved from 15 to 22 months
since 1991 [1]. Longer survival and multiple treatment
options enable multiple lines of cancer treatments. Indeed,
surveys of clinical practice in the USA suggest that women
with advanced breast cancer receive an average of four to
six lines of chemotherapy [2].
Progressive disease and multiple medical interventions
cause mental stress and physical impairment including
dysfunction of neuromuscular and skeletal structures [3].
For example, 70 % of breast cancer patients with advanced
disease have bone metastases causing significant pain and
functional disability [4]. Compromised functional ability
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leads to physical inactivity [5, 6], which manifests as loss
of muscle strength, impaired balance and fatigue affecting
cancer patients’ self-care and social activities. Thus,
physical inactivity due to functional impairment may cause
a vicious circle leading to a generalized weakness and
impaired quality of life (QoL) [5, 7].
The aim of cancer patient’s rehabilitation is to restore
and improve functional abilities, physical independence,
and thus maintain quality of life. Physical activity and
exercise training of breast cancer patients with early stage
of the disease and cancer survivors is shown to improve
physical functioning, QoL and to reduce fatigue [8], but
only limited evidence is found in patients with advanced
cancer [9]. Yet, there is little evidence of the rehabilitation
needs in advanced cancer [9].
The data of QoL of cancer patients with advanced dis-
ease is mainly based on new anticancer treatment inter-
ventions where QoL is not the primary objective [10].
According to questionnaire based on cross-sectional stud-
ies of QoL of patients with advanced disease, QoL is
however, generally impaired and the symptom burden is a
significant problem where pain, fatigue, and emotional
distress being the leading problems [11, 12].
The present study is an open, non-randomized, prospec-
tive cross-sectional observation study with the primary
objective to evaluate the functional capacity of women with
advanced breast cancer during their chemotherapy treat-
ment. The secondary endpoint is their quality of life.
Patients and methods
Patients
211 voluntary, consecutive females at the outpatient unit of
HUS, Department of Oncology during the year 2009 par-
ticipated in the study. The inclusion criteria were age
18 years or older, and ongoing treatment for metastatic
breast cancer. Of 211 patients, 155 gave a written informed
consent to participate. Later 27 patients canceled their
appointment for physical testing because of unsuit-
able timetable or illness. Finally, 128 patients were tested.
The overall recruitment rate was 61 %.
The local Ethical Committee of Helsinki University
Hospital approved the study protocol. The trial has been
registered in the Helsinki and Uusimaa Hospital District
Clinical Trials Register (http://www.hus.fi) with the unique
trial number 233307.
Measures
The physical functioning was tested by the same experi-
enced physical therapist. The test pattern was selected in
consideration of bone metastases not to predispose patients
to a risk of trauma by high resistance or extreme ranges of
movements in testing.
Physical performance
The respiratory function was evaluated by measuring the
peak expiratory flow (PEF, l/min) [13]. Three measure-
ments were taken and the best value was chosen.
The dynamic balance was measured using 6 meter
backwards-walking (walking speed) compared with the
reference values of healthy women aged 31–60 [14]. The
results are scaled from 1 ([31 s/poor) to 5 (\18 s/excel-
lent), where 3 is a moderate/fair result. In the present study
levels 4 and 5 were not tested, as they should have been
performed on a block of wood. The static balance was
tested using one foot stance (time in seconds) in two dif-
ferent ways (TOIMIVA and UKK tests). The age-related
reference values were used for women aged 20–70 years
[15] and 70–89 years [16] in TOIMIVA test, and from 25
to 60 years [17] in UKK test.
Two walking tests were performed: 10 meters walking
at maximum speed [18] with reference values for normal
population aged 13–80 years [19] and six minute walking
distance (6MWD) test by using standardized formulas
modulated by Enright and Sherrill [20]:
6MWDpredicted ¼ 2:11 heightðcmÞ
 
 2:29 weightðcmÞ
 
 5:78 ageð Þ
þ 667 m
where LLN was (6MWD-139 m).
Sit-to-stand test was performed by recording the time
taken for five repetitive stand up’s from a sitting position
[21]. The reference values for women aged from 55 to 80
were used [22]. In the repetitive squatting test, the patient
squats and gets up at an even pace as many times as pos-
sible (up to 50 times). The reference values for women
aged 35–54 were used [23].
The ROM of the shoulder joint was measured with a
goniometer. The degrees were scaled from grade 1 to 5 and
ranges from 3 to 5 were considered as normal/good for
functioning [17]. The grip strength was measured with a
dynamometer and the results were compared with refer-
ence values for Finnish adults [24].
QoL and physical functioning
The RAND SF-36-Item health survey evaluates general
health and wellbeing in eight dimensions: experienced
general health, physical functioning, role limitation due to
physical health problems, or emotional problems, pain,
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general health perceptions, vitality, general mental health,
subjective change of health status over the past year [25].
The four dimensions of RAND-36: experienced general
health, physical functioning, role limitation due to the
physical health problems and pain, were also aggregated
into one summary measure, the physical component.
The 30-item EORTC QLQ-C30 health questionnaire is
composed of five functioning scales (physical, role, emo-
tional, cognitive and social), three symptom scales (nausea/
vomiting, pain and fatigue) and a scale of global QoL. In
addition, the questionnaire contains six single items for
assessing financial difficulties, dyspnoea, diarrhea, appetite
loss, sleep disturbances, and constipation. High scores for
functional scales and for a global health score represent a
high/healthy level of functioning. High scores for symptom
scales represent a higher level of symptoms [26]. Gener-
ally, a 10-point change or more has been considered to be
clinically significant.
The patients filled the health assessment questionnaire
(HAQ) to assess self-reported physical functioning in daily
activities [27] including dressing and grooming, rising,
eating, walking, hygiene, reach, grip, and community
activities. It is expressed on a scale from 0 (no functional
disability) to 3 (severe functional disability).
Depressive symptoms were assessed using the Finnish
modified version of Beck’s 13-item depression scale (BDI)
[28]. The point sum measures the depth of the depression
symptoms: 0–4 points signifies no depressive symptoms,
5–7 mild, 8–15 moderate and 16–39 suggest severe
depressive symptoms.
Pain at present, during movement, during the past week
and the interference of pain during daily activities were
measured by using a numeric rating scale (NRS) from0 to 10.
The medical history of the patients was surveyed, and
the weight and height were measured so that body mass
index (BMI, body weight in kg/square of height in meters)
was calculated.
Statistical analyses
The data is presented as means with standard deviations,
medians with inter quartile ranges or as counts with per-
centages. The most important outcomes are given with 95
per cent confidence intervals, which were obtained by bias-
corrected bootstrapping (2000 replications) for the RAND-
36 dimensions. The Finnish general population values for
the eight RAND-36 dimensions were weighted to match
the age distribution of the study population. The compar-
isons between study patients and Finnish general popula-
tion values in RAND-36 dimensions were made by a
simulation-based t test.
Analysis of variance, Kruskal–Wallis rank test or Chi
square test was used to detect differences between three
groups. The linearity was tested, by using analysis of
covariance with an appropriate contrast and age as a
covariate. In the case of dichotomous outcome a logistic
regression was used. The factors associated to physical
health component in RAND-36 were investigated by an
ordered logistic regression models. The dependent vari-
able, physical health component, was divided into tertiles,
and both univariate and multivariate forward stepwise
models were adapted.
Results
Demographic data
Demographic data was presented in Table 1. 43 patients
(33.6 %) had an ideal weight (BMI 18.5–24.9), 1 (0.8 %)
was underweight (BMI \18.5), 52 (40.6 %) were over-
weight (BMI 25–30) and 32 (25 %) were obese (BMI
C30).
The median time elapsed from the primary diagnosis of
breast cancer was 6 years (0–20 years) and the time from
the primary diagnosis to that of the metastases was median
to 3 years (0–12 years). The metastases located in the
skeleton (N = 95, 74.2 %), liver (N = 60, 46.9 %), lungs
(N = 32, 25.0 %), brain (N = 11, 8.6 %) and in various
other organs (N = 48, 37.5 %). Seventy nine patients
(61.7 %) had multiple sites of metastases.
Treatments
A total of 62 patients (48.4 %) had undergone surgery of
the right breast, 71 patients (55.5 %) had prior surgery of
the left breast, 13 (10.2 %) had received bilateral breast
surgery, and in 8 women (6.3 %) the primary tumor of the
breast had not been managed surgically.
The most common chemotherapy agents used were doc-
etaxel (N = 100, 78 %), anthracycline (N = 40, 31 %),
paclitaxel (N = 27, 21 %), capecitabine (N = 23, 18 %),
vinorelbine (N = 15, 12 %) and gemcitabine (N = 13,
10 %). The mean number of chemotherapy lines were 2
(range 1–7); 42 %had first line chemotherapy; 25 % second;
15 % third; 13 % fourth to seventh line. Ninety patients
(70 %) were treated with endocrine therapies; aromatase
inhibitors 83 (65 %) and tamoxifen 37 patients (29 %).
Trastuzumab was used in 46 women of 128 (36 %).
Reviewed approximately after a year later in July 2010,
27 patients (21 %) had died.
Physical functioning
The main results concerning physical performance are
represented in Table 1.
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In the age group B61 years, the dynamic balance was
low in 73 % and the static balance was low in 42 %
(Table 1). Among the patients aged[60 years, the static
balance was poor in 55%, and 73 % did not even manage
to complete the dynamic balance test (Table 1). Both
dynamic (p = 0.0018) and static (p = 0.001) balance
correlated positively with the physical component of QoL
(Fig. 1).
The sit-to-stand time was extended in 30 % of patients
C55 years. More than half of the patients could not perform
the test as it was too demanding. The repeated squatting test
was lowered in 73 % of the patients in age group B55 years
where 43 % could not perform any squats (Table 1).
The right arm was dominant in 120 and the left in 8
patients. The grip strength was below normal in 43.8 % on
the right and in 30.5 % on the left upper arm. It was
symmetrical in 98 patients (76.6 %) (Table 1). The
shoulder movement was symmetrical in 107 patients
(83.6 %). Of patients with restricted ROM, 27 (21.1 %)
had grade 1 movement, 11 (8.6 %) had grade 2, 54
(42.2 %) grade 3, 6 (4.7 %) grade 4 and 30 (23.4 %) grade
5 movement. Of 21 patients with asymmetric movement,
the operated side of 19 patients (90 %) was worse.
Symptoms
In EORTC-C30 questionnaire, majority of the patients
reported symptoms as fatigue (95 %, moderate or severe
N23 %), pain (83 and 21 %) and insomnia (58 and 20 %),
dyspnea (41 and 8 %), constipation (38 and 17 %), appetite
loss (37 and 17 %), diarrhea (28 and 3 %) and nausea/
vomiting (27 and 3 %).
Table 1 The characteristics of patients and physical performance
Variable N (tested %) Result (mean) SD Range Normal N (%) Lowered N (%)
Age (years) 128 60 34–84
BMI 128 27.2 5 16–44
Multiple metastases 79 (62)
Chemotherapy (IQR) 122 (95)
Physical functioning
PEF (L/min) 128 (100) 377 84 200–590 58 (45) 70 (55)
Dynamic balance (B60 years) (s/6 m) 62 (48) 16.4–50.0 17 (27) 45 (73)
Dynamic balance (C61 years) (s/6 m) 59 (46) 16.4–50.0 11 (19) 48 (81)
Static balance, UKK (B60 years) (s/60 s) 62 (48) 37.3 23 0–60 34 (55) 26 (42)
Static balance, TOIMIVA (61–69 years) (s/60 s) 37 (29) 20.3 9.6 0–60 14 (38) 23 (62)
Static balance, TOIMIVA (C70 years) (s/60 s) 18 (14) 12.5 10 0–60 7 (39) 11 (61)
10 m walking time (all age groups) (s) 128 (100) 6.1 2 3.7–14.6
10 m walking time (B60 years) (s) 56 (44) 5.2 1
10 m walking time (C61 years) (s) 72 (56) 6.7 2.3 30 (42) 42 (58)
6 MWD (m) 111(87) 426 194 0–710 55 (50) 56 (50)
Sit-to-stand (all age groups) (s) 128 (100) 13.8 6.6 7.1–57.0
Sit-to-stand (C55 years) (s) 93 (73) 14.5 7 7.1–33.8 65 (70) 28 (30)
Repeated squat (B55 years) (number of squats) 44 (34) 9 14 0–50 12 (27) 32 (73)
Shoulder movement (grade 1–5) 128 (100) 3 1.4 1–5 90 (70) 38 (30)
Grip strength, right arm (kg) 128 (100) 24.7 6.5 0–40 72 (56) 56 (44)
Grip strength, left arm (kg) 128 (100) 23.6 6.3 0–38 89 (70) 39 (30)
Symptoms
Pain intensity (NRS 1–10)a 121 (95) 3.90 2.9 0–10 21 (17) 100 (83)
Pain in movement (NRS 1–10)a 127 (99) 3.2 3 0–10 55 (43) 72 (57)
Disability caused by pain (NRS 1–10)a 126 (98) 4.4 3.2 0–10 24 (19) 102 (81)
Physical functioning (HAQ) (1–3)b 128 (100) 0.35 0.4 0–1.9 58 (45) 70 (55)
Depression (BDI)c 119 (93) 4.3 3.6 0–18 75 (63) 44 (37)
The correlation between QoL and the functional capacity is presented in tertiles according to the level of physical quality of life
a Normal = free of pain
b Normal = 0
c Normal = 0–4
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The mean intensity of pain during the previous week
was 3.9 (SD 2.9). Twenty one patients (17.4 %) reported
no pain. Experienced pain was mild (1–3) in 38 patients
(31.4 %), moderate (4–5) in 28 patients (23.1 %), severe
(6–7) in 18 patients (14.9 %) and very severe (8–10) in 16
patients (13.2 %) (Table 1).
QoL
All patients responded to the RAND SF-36 questionnaire.
Patients in this study had significantly lower values in
general health perceptions [43.1 (SD 18.5)], bodily pain
[59.7 (SD 25.6)], physical functioning [59.6 (SD 26.7)],
role functioning [33.6 (SD 40.2)], social functioning [68.5
(SD 26.6)] and in vitality [55.3 (SD 22.0)]; no differences
were found in mental health [73.4 (SD 17.9)] or emotional
role functioning [60.2 (SD 44.7)] as compared to general
Finnish population (Fig. 2).
The EORTC QLQ-C30 functional scores were generally
lower compared to healthy population (Table 2).
Almost half of the patients reported some minor diffi-
culties in self-assessment of physical functioning measured
by HAQ.
Depressive mood was defined in 37 % of the patients.
From these patients, 25 had mild, 17 moderate and 2 had
severe depressive disorders (Table 1).
Factors associated with the physical component
of quality of life
Patients age adjusted with the physical performance was
presented according to three tertiles of the RAND-36
physical component in Table 3. In univariate analysis,
depression, pain, poor 10 meters walking speed, 6MWD,
poor sit-to-stand test time and older age correlated with the
impaired physical component of QoL; in forward stepwise
ordered logistic regression analysis, depression, pain and
6MWD appeared to be the most important determinants of
the physical component of QoL (Table 4).
Discussion
In the present prospective observational study, we found
significant impairments in physical functioning of women
with metastatic breast cancer during their cancer
chemotherapy. Quality of life (QoL) was also most sig-
nificantly impaired in the area of role physical functioning.
In fact, impaired physical functioning (muscle strength and
exercise capacity), depression and pain were the only
Physical health component
Low Moderate High
%,rettebrola
mro
N
0
20
40
60
80
100
Dynamic
Static
Fig. 1 Proportions of patients having normal or better result in
balance tests according to physical component tertiles. Patients under
61 years were included
RAND36 score
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noisne
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p<0.001
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Fig. 2 The scores for the functional scales of RAND SF-36 (means
with 95 % CIs) in study population. The dashed line shows the scores
in the general Finnish population weighted to match the age of the
study population
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independent factors negatively associated with the physical
component of QoL.
The rehabilitation needs of patients with advanced
cancer are poorly recognized and inadequately met. As
demonstrated by Cheville et al., various physical impair-
ments were identified in more than 90 % of 163 patients
with advanced breast cancer [3]. However, physical
impairments are only a part of the burden, which threatens
the functioning and QoL of cancer patients with advanced
disease. Distressing symptoms like pain and fatigue toge-
ther with total number of functional impairments accounted
for up to two-thirds of the variance in functional outcomes
[9]. This is in line with our observation, where, in addition
to impaired physical functioning, distressing symptoms
Table 2 The functional scores
from 0 to 100 from the EORTC
QLQ-C30 for study population
and for the Swedish general
population [40]
Study population (N = 128) Swedish general population (N = 1616)
Mean SD Mean SD
Global health status 61.5 20.38 74.7 22.2
Physical function 64.9 22.10 88.0 17.7
Role function 68.2 26.45 86.0 24.4
Emotional function 79.3 18.39 78.3 21.9
Cognitive function 83.1 20.05 88.5 17.7
Social function 78.2 23.71 90.4 19.6
Table 3 Characteristics of patients and physical performance according to the tertiles of the RAND-36 physical component, adjusted by age
Variable Physical component of QoL, tertiles p value All (N = 128)
Low (N = 43) Moderate (N = 41) High (N = 44)
Age, years, mean (SD) 62 (12) 62 (10) 57 (11) 0.036 60
BMI, mean (SD) 27.5 (5.4) 27.0 (4.7) 27.1 (4.9) 0.88 27.1 (4.9)
Multiple metastases, n (%) 27 (63) 27 (66) 25 (57) 0.68 79 (62)
Chemotherapy, median (IQR) 2 (1, 2) 1 (1, 3) 2 (1, 3) 0.93
Physical functioning
PEF, l/min, mean (SD) 349 (89) 385 (88) 396 (69) 0.057 377 (84)
Normal or better, n (%) 15 (35) 20 (49) 23 (52) 58 (45)
10-meter walking test, s
ALL, mean (SD) 7.3 (2.5) 5.7 (1.6) 5.1 (1.0) \0.001 6.1 (2.0)
C60 years, mean (SD) (n = 72) 8.2 (2.7) 6.1 (1.8) 5.6 (1.1) \0.001 6.7 (2.3)
C60 years, normal or better, n (%) 7 (27) 14 (50) 9 (50) 30 (42)
6 min walking time, m, mean (SD) 315 (212) 463 (177) 499 (140) \0.001 426 (194)
CLower limit of normal (LLN), n (%) 25 (58) 35 (85) 40 (91) 100 (78)
Sit-to-stand test, s
ALL, mean (SD) 16.9 (8.8) 13.3 (4.9) 11.3 (3.7) \0.001 13.8 (6.6)
C55 years, mean (SD) (n = 93) 18.1 (9.5) 13.5 (5.1) 12.3 (4.2) 0.0049 14.6 (7.0)
Normal or better (C55 years), n (%) 15 (50) 28 (78) 22 (81) 65 (70)
Shoulder movement, range
Normal or better, n (%) 23 (53) 30 (73) 37 (84) 0.0019 90 (70)
Grip strength, kg
Right upper extremity 23.3 (6.2) 24.7 (5.5) 26.0 (7.3) 0.048 24.7 (6.5)
Normal or better, n (%) 24 (56) 23 (56) 25 (57) 72 (56)
Left upper extremity 21.4 (6.5) 23.6 (5.7) 25.9 (6.0) 0.0089 23.6 (6.3)
Normal or better, n (%) 24 (56) 32 (78) 33 (75) 89 (70)
Symptoms
Pain NRS score, mean (SD) 6.0 (2.6) 3.7 (2.6) 2.2 (2.1) \0.001 3.9 (2.9)
BDI score, mean (SD) 6.3 (4.3) 4.1 (2.5) 2.4 (2.5) \0.001 27.2 (5)
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like pain and depression were independently associated
with the physical component of QoL.
Functional impairment
Impaired muscle strength of the lower extremities and
walking ability are storing indicators of functional
impairments. In the present study, the muscle strength and
endurance of the lower extremities were reduced in at least
every third patient and the walking ability in more than
every second patient. This is in line with Cheville´s previ-
ous observation, where approximately half of the patients
had lowered muscle strength and one-third of the physical
impairments were exertional [9]. In addition, in our study,
the majority of the patients had poor balance, especially
dynamic balance (78.1 %). Balance is generally strongly
related to the muscle strength of the lower extremities.
However, neurotoxic chemotherapy agents, especially
taxanes, were widely used in the treatment of our patients
which are known to cause peripheral neuropathy [29].
Impaired muscle strength together with peripheral neu-
ropathy can significantly impair balance and walking
ability, and thus increase the risk of falls [30].
As the muscle strength of the lower extremities and
walking ability reflect functional impairments, the grip
strength is associated with general frailty and mobility
limitations [31]. In breast cancer patients, impaired grip
strength could also be related to previous axillary operation
and radiotherapy. However, in the present population, the
bilateral impairment of grip strength seemed to reflect
general frailty rather than a consequence of surgery and
radiotherapy.
Functional disability
The physical impairments begin to develop quite early
during the illness trajectory. Loss of the ability to perform
at least one activity of daily living (ADL) is seen already
12 months before death especially in frail people [32]. In
the present study, more than half of the patients reported
some functional disabilities despite of the relatively good
life expectancy. Similar to the present study, Cheville
reported a significant number of patients with some func-
tional disability, and one-third of the patients were
described as moderately disable [9]. However, to discover
the rehabilitation needs, screening disabilities do not
address the cause of the inability to rehabilitate. Using the
common functional scales is also problematic as ceiling
effect limits the discriminatory capacity of these scales
[33]. Therefore, measuring the physical impairments could
be more informative for planning rehabilitation.
Symptoms
Impaired physical functioning and cancer or treatment
related symptoms are interrelating. Distressing symptoms
could further reduce patient’s functional capacity and
impair QoL. In line with the previous literature, fatigue,
pain and insomnia were the most common symptoms in the
present population [34]. Fatigue is an activity limiting
symptom [7] that affects cancer patients’ functional
capacity [35]. Fatigue has a strong influence on QoL and
especially interferes with role functioning [35]. In addition
to fatigue, more than half of our patients experienced pain
during movement, which may further decrease physical
Table 4 Univariate and multivariate stepwise ordered logistic regression models for the RAND-36 physical health component
Variables Univariatea p value Multivariateb p value
OR (95 % CI) OR (95 % CI)
Age 0.96 (0.93–0.99) 0.016
BMI 0.98 (0.92–1.04) 0.51
Multiple metastases 0.78 (0.40–1.52) 0.47
Given chemotherapy lines 1.14 (0.89–1.45) 0.30
Sit-to-stand test 0.86 (0.78–0.94) \0.001
Grip strength, normal or better (dominant hand) 1.03 (0.97–1.10) 0.28
6MWD 1.00 (1.00–1.01) \0.001 1.01 (1.00–1.01) \0.001
10-meter walking time 0.54 (0.41–0.72) \0.001
Pain NRS score 0.65 (0.56–0.75) \0.001 0.63 (0.53–0.76) \0.001
BDI score 0.70 (0.61–0.80) \0.001 0.70 (0.59–0.82) \0.001
Dependent variable is divided into tertiles
OR odds ratio
a Adjusted with age
b Forward stepwise logistic regression model; only variables entered the model are shown
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activity. Hence, we found pain as one of the most signifi-
cant variable influencing on physical component of QoL.
QoL
In the present study, the patients experienced significantly
lowered QoL as compared to the general population,
especially in physical, role and social functioning. This
became evident with all instruments used, including
generic (RAND SF-36) and disease specific (EORTC-
C30) surveys. This is in line with the previous studies of
advanced and localized breast cancer [11, 12]. In early
stage of the disease, QoL is generally less significantly
impaired than in advanced cancer, but the functioning’s
most affected are equal [11, 12]. Thus, patient’s ability to
function seems to be the key element of cancer patients
QoL. Despite of less significantly impaired emotional
functioning; the prevalence of depression in the present
study population (37 %) was significantly higher than the
prevalence in the general population in Finland (from 4.9
to 9.3 %) [36], and within patients with early stage breast
cancer (25.7 %) [35]. This is in line with the previous
studies, where the rate of depression and other psycho-
logical morbidities in breast cancer patients seems to be
highest among severely ill and hospitalized patients (up to
40 %) [37, 38]. Mood disorders could further worsen
physical symptoms and increase the risk of poor physical
functioning [39]. In the present study, impaired functional
ability, depression and pain appeared to be the most
important determinants for the physical component of
QoL [35].
Our study has several limitations. Firstly, the recruit-
ment rate was somewhat low (61 %). It is possible that the
most vulnerable patients or patients most emotionally dis-
tressed did not participate. This, however, would rather
have underestimated than overestimated the functional
impairments and impaired QoL of the population. Sec-
ondly, the physical function tests used were not planned
and validated, particularly for cancer patients with
advanced disease. The lack of age-matched reference val-
ues for all age groups further complicated the conclusions.
Thirdly, we did not perform a physical examination or
analyze the relationship between metastatic lesions and
functional impairments in individual patients.
In summary, the present study indicates that the
general functional capacity and QoL of breast cancer
patients with metastatic disease are significantly low-
ered. Impaired physical functioning together with activ-
ity limiting symptoms, like pain, fatigue and depression
can cause a vicious circle further impairing physical
capacity and QoL, leading to functional disabilities.
Pain, depression, impaired muscle strength and exercise
capacity, were independently associated with reduced
physical component of QoL. Systematic screening of
adverse symptoms and a simple tests of physical func-
tioning like the sit-to-stand test (muscle strength) might
help the healthcare professionals to identify the patients
in the greatest need of rehabilitative interventions.
Exercise improves physical functioning, mood and the
feeling of fatigue, and thus improves the QoL of cancer
patients with local disease. Further, prospective con-
trolled studies are needed to assess the benefits of
exercise and physical rehabilitation in cancer patients
with advanced disease.
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